News
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
Ansa on MSN6h
Italo-US team in ALS diagnosis breakthrough
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...
HealthDay on MSN23h
FDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...
Apr. 30, 2025 — Reduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS).
Futurism on MSN4d
Scientists Say They’ve Found a Way to Vocalize the “Inner Voices” of People Who Can’t Speak
New advances in brain-computer interface (BCI) technology may make speech for those who've lost the ability to do easier than ...
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...
Masitinib for treating amyotrophic lateral sclerosis [ID967]Following on from information provided to NICE by the company in February 2018, the appraisal of Masitinib for treating amyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback